Publications
10
Citations
61
Est. group size
—
Recurring co-author estimate
Active years
26
Publishing since 2001
K. Ceyhan's available publication record is very limited, with only a handful of records in the provided data. The single identified recent publication concerns beta-hydroxybutyrate, a metabolic molecule produced during fasting or low-carbohydrate states, and its role in regulating protein quality control (proteostasis) in the aging brain and in Alzheimer disease. The listed OpenAlex topic scores (cardiovascular risk, hypertension, diabetes, rheumatoid arthritis, genetic epidemiology) all show zero relevance, suggesting these may not accurately reflect this researcher's actual focus based on the limited data available.
The data show no recorded publications from 2017 to 2023, followed by an apparent uptick starting in 2024, though the overall record is too sparse to characterize a clear trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain
Cell chemical biology · 2024
- Gene Therapy×2
- Cell chemical biology×1
- Azariyas A. Challa
Medicine · The Ohio State University
- Andrew N. Carley
Medicine · The Ohio State University
- Aaron J. Trask
Medicine · The Ohio State University
- Alexandria Miller
Medicine · The Ohio State University
- Brett Meyers
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile